NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 59 filers reported holding NEOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $17,000 | -54.1% | 11,661 | -54.1% | 0.00% | – |
| Q3 2019 | $37,000 | +48.0% | 25,404 | +29.1% | 0.00% | – |
| Q2 2019 | $25,000 | -83.8% | 19,679 | -67.1% | 0.00% | – |
| Q1 2019 | $154,000 | +54.0% | 59,848 | -2.3% | 0.00% | – |
| Q4 2018 | $100,000 | -83.5% | 61,269 | -51.2% | 0.00% | – |
| Q3 2018 | $606,000 | -11.3% | 125,444 | +14.6% | 0.00% | – |
| Q2 2018 | $683,000 | +130.0% | 109,476 | +204.5% | 0.00% | – |
| Q1 2018 | $297,000 | -47.1% | 35,956 | -34.7% | 0.00% | – |
| Q4 2017 | $561,000 | +189.2% | 55,089 | +156.9% | 0.00% | – |
| Q3 2017 | $194,000 | +24.4% | 21,443 | -0.5% | 0.00% | – |
| Q2 2017 | $156,000 | +550.0% | 21,551 | +537.0% | 0.00% | – |
| Q1 2017 | $24,000 | -51.0% | 3,383 | -61.0% | 0.00% | – |
| Q4 2016 | $49,000 | +113.0% | 8,676 | +137.0% | 0.00% | – |
| Q3 2016 | $23,000 | -95.4% | 3,660 | -93.2% | 0.00% | – |
| Q2 2016 | $497,000 | -4.6% | 53,672 | +11.0% | 0.00% | – |
| Q1 2016 | $521,000 | +161.8% | 48,373 | +244.7% | 0.00% | – |
| Q4 2015 | $199,000 | – | 14,033 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DSC Advisors, L.P. | 1,043,770 | $7,620,000 | 2.51% |
| Stonepine Capital Management, LLC | 565,100 | $4,125,000 | 2.23% |
| DAFNA Capital Management LLC | 209,873 | $1,532,000 | 1.09% |
| Ghost Tree Capital, LLC | 500,000 | $3,650,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,459,195 | $10,652,000 | 0.57% |
| PURA VIDA INVESTMENTS, LLC | 150,000 | $1,095,000 | 0.44% |
| J. Goldman & Co LP | 845,000 | $6,169,000 | 0.33% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 191,729 | $1,400,000 | 0.20% |
| Opaleye Management Inc. | 50,000 | $365,000 | 0.15% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 50,000 | $365,000 | 0.15% |